Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiming Luo

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Frontiers in Medicine|December 5, 2025
Efficacy of acupuncture for motor dysfunction in early Parkinson's disease: protocol for a randomized, single-blind, sham-controlled clinical trialQifu Li, Yuquan Shen, Yangyang Wang, et al.
Journal of Neuroinflammation|June 30, 2016
Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in ratJin-Ya Wang, Ya-Ni Huang, Chong-Chi Chiu, et al.
Biochemical and Biophysical Research Communications|August 3, 2025
Monoterpenoid fluorophthalimide IMiDs that lack human cereblon binding: synthesis and anti-proliferative, anti-angiogenic and anti-inflammatory activitiesWeiming Luo, Kathleen M Garchitorena, David Tweedie, et al.
Scientific Reports|July 10, 2026
Memory B cells in mature follicle-like tertiary lymphoid structures predict BCG response in non-muscle-invasive bladder cancerHaitao Wang, Ying-Ang Ji, Weiming Luo, et al.
Frontiers in Immunology|December 24, 2025
SWI/SNF complex alterations predict immunotherapy response in bladder cancerJian Zhang, Yapeng Wang, Qian Yan, et al.
ACS Pharmacology & Translational Science|April 16, 2021
<i>N</i>-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS ChallengeShih Chang Hsueh, Weiming Luo, David Tweedie, et al.
Molecules (Basel, Switzerland)|December 5, 2020
Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide AnalogsMegan L Peach, Shaunna L Beedie, Cindy H Chau, et al.
Journal of Biomedical Science|March 5, 2023
Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injuryDaniela Lecca, Shih-Chang Hsueh, Weiming Luo, et al.
International Journal of Molecular Sciences|October 24, 2018
Pomalidomide Ameliorates H₂O₂-Induced Oxidative Stress Injury and Cell Death in Rat Primary Cortical Neuronal Cultures by Inducing Anti-Oxidative and Anti-Apoptosis EffectsYan-Rou Tsai, Cheng-Fu Chang, Jing-Huei Lai, et al.
Elife|June 27, 2020
3,6'-dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activationChih-Tung Lin, Daniela Lecca, Ling-Yu Yang, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Frontiers in Medicine|December 5, 2025
Efficacy of acupuncture for motor dysfunction in early Parkinson's disease: protocol for a randomized, single-blind, sham-controlled clinical trialQifu Li, Yuquan Shen, Yangyang Wang, et al.
Journal of Neuroinflammation|June 30, 2016
Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in ratJin-Ya Wang, Ya-Ni Huang, Chong-Chi Chiu, et al.
Biochemical and Biophysical Research Communications|August 3, 2025
Monoterpenoid fluorophthalimide IMiDs that lack human cereblon binding: synthesis and anti-proliferative, anti-angiogenic and anti-inflammatory activitiesWeiming Luo, Kathleen M Garchitorena, David Tweedie, et al.
Scientific Reports|July 10, 2026
Memory B cells in mature follicle-like tertiary lymphoid structures predict BCG response in non-muscle-invasive bladder cancerHaitao Wang, Ying-Ang Ji, Weiming Luo, et al.
Frontiers in Immunology|December 24, 2025
SWI/SNF complex alterations predict immunotherapy response in bladder cancerJian Zhang, Yapeng Wang, Qian Yan, et al.
ACS Pharmacology & Translational Science|April 16, 2021
<i>N</i>-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS ChallengeShih Chang Hsueh, Weiming Luo, David Tweedie, et al.
Molecules (Basel, Switzerland)|December 5, 2020
Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide AnalogsMegan L Peach, Shaunna L Beedie, Cindy H Chau, et al.
Journal of Biomedical Science|March 5, 2023
Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injuryDaniela Lecca, Shih-Chang Hsueh, Weiming Luo, et al.
International Journal of Molecular Sciences|October 24, 2018
Pomalidomide Ameliorates H₂O₂-Induced Oxidative Stress Injury and Cell Death in Rat Primary Cortical Neuronal Cultures by Inducing Anti-Oxidative and Anti-Apoptosis EffectsYan-Rou Tsai, Cheng-Fu Chang, Jing-Huei Lai, et al.
Elife|June 27, 2020
3,6'-dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activationChih-Tung Lin, Daniela Lecca, Ling-Yu Yang, et al.
Pageof 6